retatrutide type 2 diabetes phase 2 results 2024 2025 🚨 Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ Effects of retatrutide, dulaglutide, and

- 3 mg (3000 mcg)**: The highest dose available, providing maximum benefits for appetite suppression and weight loss

2, 13 Dec

These are generally most pronounced when starting or increasing doses and tend to diminish over time as the body adjusts

Health management decisions should occur with physician guidance

Retatrutide UK Legal Status Not a controlled substance in the UK Legal to supply for laboratory research purposes Astra Labs fully research-use-only compliant Not approved for human consumption Not a licensed medicine no MHRA authorisation For the full breakdown: Are Peptides Legal in the UK

Experts stress caution in extrapolating these findings to humans and call for clinical trials to clarify how weight loss drugs affect muscle size and strength